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HUBUNGAN GERBANG GIGI DALAM BUKAN-SINDROMIK BERAT SEBELAH 
BIBIR DAN LELANGIT REKAH ( UCLP ) ANAK-ANAK PAKISTAN 
ABSTRAK 
Di peringkat global, satu daripada setiap 700 kelahiran dipengaruhi oleh sumbing bibir dan 
lelangit. Setiap kadar kelahiran, ia adalah salah satu kongenital anomali kelahiran orofacial 
yang paling biasa. Kajian lepas menunjukkan bahawa sumbing bibir dan lelangit dipengaruhi 
pelbagai faktor, tetapi genetik dan faktor alam sekitar memainkan peranan yang penting dan 
telah dikaji secara meluas secara individu dan bersama. Penglibatan pelbagai pihak adalah 
penting untuk memastikan pengurusan rawatan sumbing bibir dan lelangit berkesan. 
Pembedahan utama membaikpulih fungsi dan struktur. Pelbagai kaedah telah direka dan 
diamalkan dalam merawat sumbing bibir dan lelangit walaubagaimanapun tiada satu kaedah 
yang dipilih menjadi kaedah utama dalam rawatan tersebut. 
Hasil rawatan kaedah pembedahan utama perlu dinilai dari factor kongenital dan postnatal. 
Kesan pembedahan ke atas pertumbuhan dan hubungkait antara faktor-faktor yang telah 
dinyatakan haruslah di audit. Dentoalveolar telah digunakan secara meluas untuk menilai hasil 
rawatan. Pelbagai indek telah direka berdasarkan darjah pertumbuhan yang berbeza.  
Terdapat kekurangan yang teruk apa-apa pengetahuan hasil rawatan dan peranan protokol 
yang berlainan di kalangan penduduk Pakistan. Matlamat kami adalah untuk menentukan 
taburan baik / tidak baik daripada hasil rawatan yang menggunakan GOSLON Yardstick, 
sistem Huddart yang diubah suai / Bodenham, dan EUROCRAN kayu pengukur. Untuk 
menilai hubungkait antara faktor rawatan kongenital dan selepas bersalin terhadap hasil 
rawatan berdasarkan indeks yang dinyatakan.  
xii 
 
101 pasangan kanak-kanak Pakistan yang menghidapi unilateral sumbing bibir dan lelangit 
dengan junlah usia min 8.05 ± 0.79 dinilai menggunakan GOSLON, MHB dan ukuran 
EUROCRAN. Min skor indeks GOSLON adalah 3.04 ± 1.25. Skor min EUROCRAN 
berdasarkan penggredan gigi adalah 2.72 ± 0.76, manakala, berdasarkan morfologi permukaan 
lelangit, skor min adalah 2.20 ± 0.73. Skor min MHB, berdasarkan 5 kumpulan adalah 2.85 ± 
1.30. 
Dengan bantuan pangkalan data yang baru ditubuhkan, kumpulan rawatan sumbing boleh 
meningkatkan dan mewujudkan sensitif berdasarkan teknik yang terkini. Min skor GOSLON 
bagi penduduk Pakistan menemukan satu hasil rawatan perantaraan dan boleh dibandingkan 
dengan kajian populasi Asia yang lain seperti Malaysia dan Jepun. Berdasarkan sistem 
pemarkahan Huddart diubahsuai / Bodenham, pesakit Pakistan mempunyai hasil rawatan dari 
baik kepada lemah. Keputusan kajian adalah lebih sensitif dilihat dari segi darjah pertumbuhan 
yang songsang. Menurut indeks EUROCRAN, berdasarkan penggredan pergigian, pesakit 
Pakistan mempunyai frekuensi yang lebih tinggi dari hasil rawatan yang lemah dan ini adalah 
lebih teruk berbanding dengan penduduk Eropah. Menurut indeks EUROCRAN, berdasarkan 
morfologi permukaan lelangit, jumlah pesakit unilateral bibir dan lelangit dari Pakistan 
mempunyai hasil yang lebih teruk berbanding dengan kajian sebelumnya. 
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DENTAL ARCH RELATIONSHIPS IN NON-SYNDROMIC UNILATERAL CLEFT 
LIP AND PALATE (UCLP) CHILDREN OF PAKISTAN 
ABSTRACT 
Globally, one out of every 700 live-births are affected by cleft lip and palate (CLP). By 
occurrence rate, it is one of the most common congenital orofacial birth anomaly. Literature 
indicates that CLP has a multifactorial origin, but genetics and environmental factors play a 
vital role and have been extensively studied individually and in conjunction. A 
multidisciplinary involvement is absolute to successfully manage and treat CLP. Primary 
surgical repairs are required to restore function and structure. Numerous designs for repair of 
CLP have been devised and practiced but the superiority of outcome following a single surgery 
over the rest has not been established. 
It is necessary to assess the treatment outcomes of these primary surgical repairs under the 
influence of congenital and post-natal factors. Audit can be performed to assess their effect on 
growth along with association of these confounding factors. Dentoalveolar relationships have 
been extensively used to assess the treatment outcome. Many indices have been developed 
which are based on different planes of growth.  
There is a severe lack of any literature of the treatment outcome and the role of different 
protocols in Pakistani population. Present study aims to determine the distribution of 
favourable/unfavourable treatment outcome by using GOSLON Yardstick, Modified 
Huddart/Bodenham system (MHB), and EUROCRAN yardstick, and to evaluate the 
association of the congenital and post-natal treatment factors on the treatment outcome based 
on these indices.  
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101 model pairs of Pakistani children having total unilateral cleft lip and palate with a mean 
age of 8.05 ± 0.79 were assessed using GOSLON, MHB and EUROCRAN yardsticks. The 
mean score for GOSLON index is 3.04 ± 1.25.The mean score of EUROCRAN based on 
dental grading is 2.72 ± 0.76, whereas, based on the palatal surface morphology, the mean 
score is 2.20 ± 0.73. The mean score of MHB, based on 5 groups, is 2.85 ± 1.30.  
With the help of present established database, teams providing cleft care can improve and 
establish protocols based on recent advanced techniques. Mean GOSLON scores, of Pakistani 
population unravel an intermediate treatment outcome and are comparable with other Asian 
population studies like Malaysia and Japan. According to Modified Huddart/Bodenham 
scoring system, Pakistani patients have a fair to poor treatment outcome. The results were 
more sensitive considering transverse planar growth. According to EUROCRAN index, based 
on dental grading, Pakistani patients have a higher frequency of poor treatment outcome, 
which was worse in comparison to the European populations. Based on palatal surface 
morphology, Pakistani TUCLP patients have the worse outcome in comparison to previous 
studies. 
 
 
1 
 
CHAPTER 1 
INTRODUCTION 
1.1 Background of study 
Cleft lip and palate (CLP) is defined as “non-fusion of the upper lip and/or the roof of the 
mouth (hard and/or soft palate) which appears as a gap in the affected structures” (Erverdi and 
Motro, 2015). One child in every 700 live-births suffers from CLP, that makes it one of the 
most commonly occurring congenital orofacial birth defects (Murray, 1995). According to a 
recent epidemiological survey in Pakistan, one child in every 523 suffers from it with a 
preponderance to males (Elahi et al., 2004). However, to the best of my knowledge no reported 
evidence till date was found on Pakistani population for treatment outcome of any type of cleft 
case. 
Previous studies indicate that CLP has a multifactorial origin (Jones, 1993; Bernheim et al., 
2006; Dixon et al., 2011). Patients suffering from CLP can be congenitally syndromic or non-
syndromic depending on the number of other associated health problems (Saal, 2002). A 
patient is considered syndromic if he/she suffers from one major or three minor health 
problems in addition of CLP. Other than the syndromes, common health problems associated 
with the non-syndromic CLP children are dental anomalies (Cassolato et al., 2009; Wu et al., 
2011), aesthetic issues (Sinko et al., 2005), hearing difficulties (Yang and McPherson, 2007), 
speech problems (Shprintzen, 2008), and psycho-social behavioural issues (Broder, 2001; 
Sinko et al., 2005). Treatment of CLP involves a multidisciplinary approach for a favourable 
treatment outcome.  
Treatment objectives involve primary surgical repair of lip and palate to restore occlusion, 
function, and aesthetics. Numerous surgical repair techniques have been devised to perform 
cleft repair, but the best has not been identified till date (Mølsted et al., 1992). Confounding 
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factors other than technique also include, timing of repair (Rohrich et al., 1996), surgical skill, 
favourable growth pattern and many other factors which have not been identified. 
To improve the treatment outcomes of these surgical cleft repairs one should identify the role 
of the reparative surgeries, their confounding factors and the association between the two. To 
audit the treatment outcome of CLP many indices have been designed based on different scales 
of measurement. The most commonly used scale of measurement to assess treatment outcome 
of CLP is the dentoalveolar relationships. 
One of the method to evaluate the dentoalveolar relationships is by assessing the dental casts 
of the patient. Since 1972, many researchers have tried to develop an audit tool which is 
suitable to measure the treatment outcome of the patient on which primary surgeries have been 
performed (Huddart and Bodenham, 1972). However, these indices came into wide use in 
1987, when Great Ormond Street, London and Oslo, Norway (GOSLON) index was developed 
(Mars et al., 1987). After which researches started to notice the importance of an audit tool 
which can be used to assess the treatment outcome and determine the benefits, advantages and 
disadvantages of the numerous surgical procedures which were in practice. 
However, GOSLON index had its own pros and cons. It selected reference dental models to 
represent different groupings of unilateral cleft lip and palate (UCLP) patients depending on 
the complexity of orthodontic treatment need. Prior training and calibration was required to 
grade dental models reliably. After a decade, an issue regarding the age of patient was raised 
(Atack et al., 1997a). A new index for young children was developed to eliminate the 
possibilities of “contamination” of patient treatment outcome till the age of ten, for example, 
alveolar bone grafting and/or orthodontic treatment, etcetera (Atack et al., 1997a). However, 
both of these indices were subjective in nature, and did not readily support true statistical 
evaluation. Both considered growth in an anteroposterior plane heavily, then transverse and 
vertical, respectively in that order. This led to the modification of the originally advised 
Huddart/Bodenham scoring system in 1997 (Heidbuchel and Kuijpers-Jagtman, 1997). 
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Through modification in the scoring system it was considered that all types of clefts at all ages 
can be measured (Heidbuchel and Kuijpers-Jagtman, 1997; Mossey et al., 2003), which came 
to be known as Modified Huddart/Bodenham scoring system (MHB). However, the index 
weighed the treatment outcome in transverse plane as heavily as anteroposterior. EUROCRAN 
index was devised recently which grades dental models in two modules. A dental scoring 
which grades the models for assessing anteroposterior and vertical growth, and a palatal 
scoring to assess the transverse growth (Fudalej et al., 2011; Patel, 2011). 
1.2 Statement of the problem 
Evidence based practice has revolutionized every field of health care. With an increase in 
epidemiological surveys, outcome effects of the treatment provided are being evaluated which 
has led to the selection of an appropriate technique, development of up to date protocols, and 
possible prevention of environmental factors that can effect treatment outcome. On the other 
hand, under developed countries like Pakistan continue to provide treatment on traditionally 
established protocols.  
In Pakistan, one in every 523 live-births suffers from some form of clefting. Yet only one 
epidemiological study has been conducted for the population of Pakistan and that also with 
the collaboration of foreign agencies (Elahi et al., 2004). CLP prevalence varies among 
different racial and ethnic groups (Croen et al., 1998). Treatment outcome of any form of CLP 
in Pakistani population has never been documented. There is scarcity of knowledge of the 
treatment outcome in Pakistani population. There is no database available to compare with 
other ethnicities, or alternatively, to longitudinally assess the treatment progress within the 
population. 
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1.3 Justification/Rationale of study 
By determining the treatment outcome using indices based on dentoalveolar relationships, we 
intend to formulate a database, which will allow comparison of Pakistani with others. It will 
also act as a baseline for future comparative studies to document any negative or positive 
influence of treatment amongst the target population. 
This will facilitate health care providers to plan a treatment, justify the modifications in 
surgeries, and to better understand the growth outcome of Pakistani population. It will reduce 
the treatment cost by timely planning of early intervention rather than delayed corrective 
procedures. Health care providers will be able to discuss the general trends of outcome with 
patients’ family. They will try to moderate parent expectations, improve motivation of 
patient/parents and reduce the burden of care by timely informed consent. Most importantly, 
this study will raise awareness among Pakistani health care professionals to document and 
practice higher standards of protocols available and help reduce CLP care burden at a social 
level.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Embryology of cleft lip and palate (CLP) 
2.1.1 Formation of upper lip 
During 6th to 7th week of embryonic development, maxillary prominences increase in size, as 
illustrated in Figure 2.1 A. These prominences also migrate medially, compressing the mesial 
nasal prominences in a mesial direction, eventually resulting in fusion of both mesial nasal 
prominences, as illustrated in Figure 2.1 B (Magreni and May, 2015). 
2.1.2 Formation of intermaxillary segment 
The fusion of mesial nasal prominences occur at a deeper level, extending horizontally, leading 
to the formation of intermaxillary segment. This comprises of philtrum of lip, upper jaw 
containing the four incisors and the primary palate as illustrated in Figure 2.2 (Magreni and 
May, 2015).  
2.1.3 Formation of secondary palate 
At the same time, the secondary palate is mainly formed by the two shelf-like outgrowths of 
the maxillary prominences. During 6th week, the horizontal palatine shelves are directed 
obliquely downwards on either side of the tongue, as illustrated in Figure 2.3. 
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Figure 2.1: Frontal view of face A. 7th week of development. B. 10th week of development. 
Medial Nasal Prominence 
Maxillary Prominence 
Lateral Nasal Prominence 
Fronto-Nasal Prominence 
A 
B 
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Figure 2.2: Ventral view of intermaxillary segment. 
Upper jaw including 
four incisors 
Philtrum of upper lip 
Primary palate 
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Figure 2.3: Ventral view of the palatine shelves at 6th week. 
Primary palate 
Palatine shelves 
Position of the tongue  
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In the 7th week, the palatine shelves attain a horizontal position above the tongue and by the 
end of 10th week, start to fuse together to form secondary palate, as illustrated in Figure 2.4 
(Magreni and May, 2015). Fusion of palatine shelves anteriorly results in the formation of 
incisive foramen. Incisive foramen is an embryological landmark demarcating the primary and 
the secondary palate. 
2.1.4 Formation of cleft lip and palate 
Failure of fusion of mesial nasal processes creates a gap or a split termed as cleft, which can 
extend from the lip up to the primary palate. Whereas, failure of fusion of maxillary 
prominences also results in the formation of a cleft involving secondary palate. This 
phenomenon of cleft formation can occur in isolation or simultaneously i.e., involving lip, 
primary and secondary palate. For example, when failure is in isolation it will be termed as 
“isolated cleft lip” (CL) or “isolated cleft palate” (CP). Whereas, in latter case “total cleft lip 
and palate” is formed. When the failure of fusion is on one side it is termed as “unilateral” but 
if both sides are involved then the resulting cleft will be termed as “bilateral” (Bernheim et al., 
2006). 
2.1.5 Classification of cleft lip and palate 
Early Veau classification was based on the increase in severity of the cleft and was classified 
into four groups (Schwartz et al., 1993). First group having a cleft of the soft palate, 2nd having 
a cleft of the secondary palate, 3rd having a cleft involving the primary and secondary palate 
thereby resulting in the total unilateral cleft lip and palate (TUCLP) and the last group having 
total bilateral cleft lip and palate (TBCLP). 
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Primary palate 
Palatine shelves 
Figure 2.4: Ventral view of the palatine shelves at 7th week forming the secondary palate. 
Location of incisive 
foramen 
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Later, Kernahan and Stark classified clefts based on the consideration of the incisive foramen 
as the reference point (Kernahan and Stark, 1958). First group having all the clefts of lip and 
primary palate up to the incisive foramen, second having clefts of the secondary palate 
consisting of the soft and hard palate and last group having combinations of both former groups 
(Tan and Henry, 1985). 
Kriens proposed LAHSHAL classification which utilized the letters L, A, H, and S to represent 
lip, alveolus, hard palate, and soft palate, respectively. It is a palindromic system representing 
both sides. To explain, suppose we classify a case having “aHS” where the upper-case letters 
represent total cleft of the hard and soft palate whereas lower-case letter represents partial cleft 
of alveolus. It gives an easy and comprehensive description of the defect (Kriens, 1989). 
Numerous other classifications have been proposed but their use has been limited depending 
upon different facets of the complex management protocols designed for CLP. For example, 
conventional surgeons widely consider that the incisive foramen based classification provides 
sufficient description of the anomaly for planning the treatment. Contemporarily, 
epidemiologists rely on a rather more objective classification to record the minute details for 
each case specifically, which would allow them to derive biologically and statistically sound 
results. Currently, the classification based on the incisive foramen is accepted and is being used 
globally (Dugas, 2010). Origin and location of the incisive foramen is illustrated in Figure 2.4. 
The classification based on incisive foramen will be used in the latter text to allow comparative 
research as it has been widely documented in the literature.  
Orofacial clefts (OFC) are also classified into syndromic or non-syndromic, on the basis of 
association with other major or minor developmental abnormalities. The importance of this 
classification has been previously expressed, to facilitate in finding the etiology, devising 
management plan, and counselling regarding recurrence risks (Saal, 2002). 
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2.2 Epidemiology of CLP 
2.2.1 Incidence rates 
According to literature, CLP has been extensively documented as one of the most commonly 
occurring hereditary orofacial birth defects (Murray, 1995). Contemporarily, it has also been 
deemed as the most common non-syndromic cranio-facial defect (Cardoso et al., 2013). It has 
been documented as the second most common general birth defect (Strong and Buckmiller, 
2001; Thong et al., 2005).  
An overall incidence of 1.43:1000 of OFC to live births , has been broadly reported in literature 
(Stanier and Moore, 2004; Dixon et al., 2011). However, significant heterogeneity among 
different ethnicities have been computed (Freni and Zapisek, 1991; Schutte and Murray, 1999). 
An overall incidence ratio of approximately 1.30:1000 among Asian population has been 
published (Cooper et al., 2006). Regarding non-syndromic clefts 1.41:1000 in Japanese, 
1.21:1000 in Chinese and 1.25:1000 in other Asian populations have been documented (Cooper 
et al., 2006; Alam et al., 2008).  
A ratio of 2.1 to 1000 has been recently reported in African native population (Akintububo et 
al., 2014). A ratio of approximately 1.06 to 1000 has been documented in a 30-year 
epidemiological study conducted in Iran (Kianifar et al., 2015). From previous studies an 
estimate of 0.98:1000 has been made in Indian population (Kharbanda et al., 2014). A range of 
0.34-2.29:1000 would be safe to represent more than 30 surveys conducted on the variety of 
Caucasian populations (Freni and Zapisek, 1991; Schutte and Murray, 1999; Mossey et al., 
2009). 
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A 
D 
B 
C 
Figure 2.5: Classification system based on embryology. 
A. Cleft lip only (CL) B. Total unilateral CLP (TUCLP) C. Total bilateral CLP (TBCLP) D. 
Cleft palate only (CP). 
B.  
Figure Legend: According to Internationally accepted classification (Millard Jr, 1976), 
Group 1: Clefts of anterior palate(primary palate) 
(lip and alveolous) (right and/or left) 
Group 2: Clefts of anterior and posterior (primary and secondary palate) 
 (lip, alveolous and hard palate) (right and/or left) 
Group 3: Cleft of posterior palate (secondary palate) 
 (hard palate and soft palate) (right and/or left) 
 Further subdivision were based on being “total” or “partial” 
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Overall 1.91:1000 was reported in an unprecedented epidemiological study in Pakistan. 42% 
cases of CL, 24% of CP and 34% cases of combined CLP were reported. Male preponderance 
was noted among CL and CLP cases, whereas females were  commonly affected by CP (Elahi 
et al., 2004). 
Unilateral cleft lip has been often associated with cleft palate in 45-68% of the cases (Kirschner 
and LaRossa, 2000). There is two-fold probability of  unilateral cleft lip extending to the palate 
(UCLP) to occur on the left side , and UCLP is nine times more common than bilateral cleft lip 
and palate (BCLP) (Habib, 1978; Kirschner and LaRossa, 2000; Kajii et al., 2013). 
2.2.2 Gender differences 
Although the specific aetiology of the sexual disparities among cleft patients is unknown, but 
literature reveals a large difference in occurrence rate among different genders. Some studies 
reveal that 60-80% of the newborns with CLP are males (Drillien et al., 1966; Nguyen and 
Sullivan, 1993; Kirschner and LaRossa, 2000; Strong and Buckmiller, 2001; Stanier and 
Moore, 2004). Moreover, males are also found to have more severe defects of CLP as compared 
to females (Cooper et al., 1979). On the contrary, females are found to have a rather frequent 
occurrence of CP (Nguyen and Sullivan, 1993; Kirschner and LaRossa, 2000; Strong and 
Buckmiller, 2001; Stanier and Moore, 2004). The effect of late embryonic fusion of maxillary 
prominences have been associated with increased risk of being exposed to teratogens leading 
to cleft formation  (Burdi and Faist, 1967). Male preponderance has also been associated with 
more severe or total CLP defects in other studies  (Converse et al., 1997). Among Japanese 
population the sexual disparities were less pronounced (Fujino et al., 1963). Female 
preponderance in CP has also been found (Fraser and Calnan, 1961). Whereas, CP extending 
to the incisive foramen has been found more common in females (Converse et al., 1997). 
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To comprehend CLP epidemiology, extensive studies involving massive geographical areas 
and a large sample size are required like the study conducted in Iran (Kianifar et al., 2015). 
Overall incidence rates have been established among different races based on hospital records, 
statistical calculations, and surveys with a lack of structural classification. The influence of, 
exclusion of still births, syndromic clefts, different types of clefts, and abortions can greatly 
under predict the incidence reported in literature (Dugas, 2010). 
2.3 Aetiology of CLP 
2.3.1 Genetic Factors 
Overall, OFC have been linked with 200-400 genetic syndromes (Wong and Hagg, 2004; 
Arosarena, 2007). However, non-syndromic clefts are more common and their genetic 
aetiology has been attributed to a single-gene locus mutation at one time or involving multiple 
sites (Jones, 1993; Strong and Buckmiller, 2001). 
To measure the genetic influence and strength of hereditary involvement on occurrence of 
clefts, concordance rates are assessed. A range of 40-60% in monozygotic twins was quoted 
in previous studies (Jones, 1993; Nguyen and Sullivan, 1993; Marazita and Mooney, 2004) 
and 5% in dizygotic twins (Murray, 2002). A 100% concordance rate is essential to declare 
genetic mutation as the sole cause of OFC (Murray, 2002). 
Various studies have been published in literature in quest of finding a genetic linkage. Various 
loci have been suggested to influence the occurrence of clefts. The findings have been briefly 
summarized in Table 2.1. CLP has been commonly associated with an autosomal dominant 
disorder known as Van der Woude syndrome (Kirschner and LaRossa, 2000). Interferon 
Regulatory Factor 6 gene has been strongly linked to this syndrome and CP (Zuchero et al., 
2004).  
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Chromosome 22q11.2 deletion has been notoriously associated with many syndrome. Namely, 
velo-cardio-facial syndrome (Sphrintzen syndrome), Digeorge syndrome, conotruncal 
anomaly face syndrome are among the most common (Shprintzen, 2008). 
2.3.2 Environmental Factors 
Environmental factors, lifestyle, health conditions, and socioeconomic background have been 
extensively documented as having a significant role in increasing or decreasing the risk of 
occurrence of clefts. Potential factors imparting effect on OFC have been briefly tabulated in 
Table 2.2. The rationale of finding these associations may not help in diagnosis or treatment of 
CLP, but it can greatly assist in planning pregnancies (Chen et al., 2007; Mossey et al., 2007). 
Hypothetically, planning pregnancies would include habitual modification, avoidance of 
unplanned pregnancies, diet counselling, genetic counselling, etc. Numerous gene-environment 
interactions regarding cleft lip and palate have also been explored by scientists. Interaction of 
smoking with RARA, TGFA, MSX1, TGFB3, P450, GST, and EPHX1, contemporaneously 
interaction of alcohol consumption with TGFA, MSX1, and TGFB3 has been extensively 
researched (Maestri et al., 1997; Romitti et al., 1999; Hartsfield et al., 2001; Mitchell et al., 
2001; van Rooij et al., 2001; Haque et al., 2015a). 
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Table 2.1: Summary of gene linkage/association studies. Adapted from (Murray, 2002) 
 
  
Gene  Locus Linkage References 
SKI/MTHFR 1p36 Positive (Shaw et al., 1998; Mills et al., 1999; Passos-
Bueno and Steman, 1999; Shaw et al., 1999; 
Blanton et al., 2000; Wyszynski and Diehl, 
2000; Martinelli et al., 2001a; Martinelli et 
al., 2001b; Vieira et al., 2005; Chevrier et al., 
2007) 
TGFB2 1q41 Negative (Lidral et al., 1997; Tanabe et al., 2000) 
TGFA 2p13 Negative (Ardinger et al., 1989; Chenevix-Trench et 
al., 1992; Holder et al., 1992; Vintiner et al., 
1992; Field et al., 1993; Shiang et al., 1993; 
Feng et al., 1994; Jara et al., 1995; Lidral et 
al., 1997; Maestri et al., 1997; Mitchell, 
1997; Pezzetti et al., 1998; Christensen et al., 
1999; Machida et al., 1999; Tanabe et al., 
2000; Zeiger et al., 2005; Vieira, 2006) 
MSX1 4p16 Positive (Lidral et al., 1997; Lidral et al., 1998; Beaty 
et al., 2001; Beaty et al., 2002) 
4q31 Both (Mitchell et al., 1995) 
6p23 Both (Scapoli et al., 1997; Pezzetti et al., 1998) 
PVRL1 11q23 Negative (Sözen et al., 2001) 
TGFB3  14q24 Negative (Lidral et al., 1997; Lidral et al., 1998; 
Tanabe et al., 2000; Beaty et al., 2001; Beaty 
et al., 2002) 
GABRB3 15q11 Negative (Tanabe et al., 2000; Scapoli et al., 2002) 
RARA 17q21 Both (Chenevix-Trench et al., 1992; Shaw et al., 
1993) 
BCL3 19q13 Both (Shaw et al., 1993; Stein et al., 1995) 
IRF6 1q32.3q41 Positive (Zuchero et al., 2004) 
TBX1 22q11.2 Both (Shprintzen, 2008) 
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Table 2.2: A summary of lifestyle and environmental risks of OFC. 
Agent Comments Selected references 
Anticonvulsant 
drugs like, 
Diazepam, 
Phenytoin, 
Phenobarbital 
A ten-fold increased risk of OFC 
has been associated with the use of 
Phenytoin. 
(Dravet et al., 1992; 
Abrishamchian et al., 1994; Shaw 
et al., 1995)  
Corticosteroids An estimated increased risk up to 
three-folds has been documented. 
(Park‐Wyllie et al., 2000) 
Benzodiazepines  A possible risk has been associated 
in two studies. 
(Safra and Oakley, 1975; Saxén 
and Saxén, 1975) 
Isotretinoin  Positive teratogenic effects on 
pregnant females and mice were 
detected. 
(Willhite et al., 1985; Jones, 1993) 
Sickness Infections during pregnancy like 
influenza, rubella, and common 
cold were significantly high 
among mothers of affected cases. 
(Natsume et al., 2000) 
Smoking  According to various studies and 
meta-analyses, an occurrence risk 
of 2-20% has been associated. 
Although the negative effects of 
public smoking, pollution, and 
passive smoking have not been 
attributed. 
(Warkany and Nelson, 1940; 
Johnston and Millicovsky, 1985; 
Lammer et al., 1985; Khoury et 
al., 1987; Van den Eeden et al., 
1990; Rothman et al., 1995; Shaw 
et al., 1996; Beaty et al., 1997; 
Croen et al., 1998; Mitchell et al., 
2003; Little et al., 2004; Tamura et 
al., 2005; Honein et al., 2007) 
Alcohol  Depending upon consumption, 
high quantities of routine 
consumption during pregnancies 
have been associated with a higher 
risk of cleft occurrence. Moreover, 
prenatal ethanol exposure has been 
known to cause lysis of neural 
crest cells, which could result in 
gene alteration or mutation. 
(Gordon and Shy, 1981; Kotch and 
Sulik, 1992; Cartwright and Smith, 
1995; Rothman et al., 1995; 
Munger et al., 1996; Croen et al., 
1998; Shaw and Lammer, 1999; 
Shaw et al., 2003) 
Multivitamin Multivitamin supplementation has 
shown 25% reduction in 
occurrence risk of clefts.  
(Tolarova, 1982; Tolarova and 
Harris, 1995; Shaw et al., 1999; 
Johnson and Little, 2008) 
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Table 2.2 (Continued)  
Agent Comments Selected references 
Folic Acid 
 
Folic acid supplementation during 
initial four months of pregnancy 
was found to have a protective 
effect against OFC and in another 
study, high doses of maternal folic 
acid supplementation have shown 
increased occurrence risk as 
compared to low doses. 
(Tolarova, 1982; Johnston and 
Millicovsky, 1985; Tolarova and 
Harris, 1995; Czeizel et al., 1996; 
Jacobsson and Granström, 1997; 
Ulrich et al., 1999; Schubert et al., 
2002) 
Socioeconomic 
status 
A feeble association of low-
income to increased occurrence 
risk has been discussed in few 
studies.  
(Sivaloganathan, 1972; Moosey 
and Little, 2002; Elahi et al., 2004) 
Exposure to 
organic solvents 
Parental exposure due to 
occupation or environment has 
been associated with an 
inconsistent risk. 
(Gordon and Shy, 1981; Garcia, 
1998; Lorente et al., 2000; Shaw et 
al., 2003) 
Vitamin B6 
deficiency 
In Asian populations, where 
polished rice is staple food, 
increased risk of OFC has been 
documented. 
(Munger et al., 2004) 
Zinc A deficiency of zinc is proved to 
cause CP. Low plasma 
concentrations of zinc increase the 
risk of OFC. 
(Warkany and Nelson, 1940; 
Krapels et al., 2004; Tamura et al., 
2005) 
Riboflavin  CP was formed in subjects with 
riboflavin induced deficiency. 
(Strean and Peer, 1956) 
Vitamin A High levels of vitamin A 
consumption were found to have 
increased teratogenic effects. 
(Rothman et al., 1995; Mitchell et 
al., 2003) 
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2.4 Impact of CLP on patients 
Unfortunately, numerous problems have been associated with non-syndromic cleft lip and 
palate patients. Associated health problems include, feeding problems (Clarren et al., 1987; 
Jones, 1993), hearing defects (Yang and McPherson, 2007), speech problems (velo-
pharyngeal dysfunction) (Al Omari and Al-Omari, 2004; Salyer et al., 2006), aesthetic 
problems (Ross and MacNamera, 1994; Sinko et al., 2005), poor cognitive functioning and 
social skills (Broder, 2001; Eiserman, 2001), paediatric and orthodontic complications 
(Devlin, 1998) and a wide list of dental anomalies (Cassolato et al., 2009; Wu et al., 2011). 
Most commonly occurring dental anomaly is congenitally missing maxillary lateral incisor of 
the cleft side (Wu et al., 2011). Crossbite and class III malocclusion have also been 
documented as the most commonly associated dental anomalies (Paradowska-Stolarz and 
Kawala, 2014). Other dental anomalies associated with CLP are, supernumerary teeth, peg 
laterals, impacted teeth, retained deciduous dentition, etcetera (Cassolato et al., 2009; Wu et 
al., 2011; Haque and Alam, 2015).  
2.5 Treatment of CLP 
Management of CLP has immensely evolved over the past century. Multidisciplinary 
approaches and new techniques for management of CLP have been introduced, discussed and 
modified. Age plays an important role while planning treatment of CLP. A flow chart of 
chronological management of CLP patients is presented in Figure 2.6. 
2.5.1 Pre-surgical infant orthopaedics 
Many intraoral devices have been introduced to facilitate feeding and controlling naso-labio-
maxillary growth. Clinical trials to assess the use of these devices suggested no significant 
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effect of pre-surgical infant orthopaedic (PSIO) devices but naso-alveolar molding (NAM) 
was not studied in these trials (Grayson and Garfinkle, 2014). However, significant clinical 
improvements with use of PSIO have also been attributed in literature (Koshikawa-Matsuno 
et al., 2014). In 2014, potential advantages and disadvantages of PSIO including NAM were 
comprehensively discussed in heated point/counterpoint articles (Grayson and Garfinkle, 
2014; Hathaway and Long, 2014). Treatment outcomes of as many as 16 inter-centre studies 
were assessed and comparatively favourable results were found among centres where non-
PSIO treatments were performed (Vig and Mercado, 2015).  
2.5.2 Cleft lip repair 
Lip repair (cheiloplasty) aims to approximate the abnormal attachments in corrected location 
with minimal scarring. Clinical anatomy of a cleft lip differs from a healthy lip as, the circular 
perioral fibers of the musculature (orbicularis oris) are obliquely attached to the caudal nasal 
septum instead of encircling the oral orifice in continuity (Anastassov and Joos, 2001; Haque 
and Alam, 2014a). Numerous techniques have been devised for the primary lip repair as shown 
in Figure 2.7.  
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Pre-natal Period 
Diagnosis by Obstetrics 
Paedodontist and 
Orthodontist for 
dental anomalies and 
orthopaedic needs 
Maxillofacial 
Surgeons and plastic 
surgeons for surgical 
consult arrangments 
Prosthodontist for 
early provision of 
obturators 
Genetics expert for 
parent counselling 
and pregnancy 
planning  
Neo-natal period 2 weeks-6 months 
NAM appliance for pre-surgical 
infant orthopaedics 
Primary surgical repair of lip and 
gingivoperioplasty 
Deciduous dentition 2-7 years 
Psychological consult, speech 
therapies and velopharyngeal repair 
Mixed dentition 7-12 years 
Combined efforts of 
orthodontist and 
maxillofacial surgeon 
Plan pre-surgical 
maxillary expansion and 
secondary alveolar bone 
grafting 
Planning of orthopaedic 
appliance for maxillary 
growth modification 
Psychological motivation, speech 
therapies 
Considerations for orthognathic 
surgeries and nasolabial revisions 
Considerations for lip and nose 
revision surgeries 
Permanent dentition 12 years to adult 
Figure 2.6: Chronological flow diagram of orofacial cleft management.  
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2.5.2.1 Tennison-Randall Technique (Tennison, 1952; Randall, 1959) 
A triangular flap was initially designed for cleft lip repair by Tennison, which was later 
modified by Randall, to improve its reproducibility with ease and precision. This technique is 
still in use by some surgeons, and it produces predictable results (Arosarena, 2007). 
2.5.2.2 Millard rotation advancement technique 
It is one of the most popular techniques being used for cleft lip repair (Millard Jr, 1961). It has 
been modified several times by surgeons belonging different school of thoughts (Millard Jr, 
1961). Advantages and disadvantages of Millard technique are numerous (Kirschner and 
LaRossa, 2000; Arosarena, 2007). Millard attempted to preserve cupid’s bow, philtral dimple, 
and improve nose prominence (Millard Jr, 1976).  
2.5.3 Cleft palate repair 
Palatal repair (palatoplasty) aims to create a physical barrier between oral and nasal cavities. 
Surgical repair of soft and hard palate is performed generally around 6-9 months of age. Two 
most important factors in determining surgical outcome are timing of surgery and technique 
of palatoplasty used (Kirschner and LaRossa, 2000; Lilja et al., 2006). However, delayed 
palatal closure has been linked with poor speech outcomes, though it remains debateable. 
Many surgical techniques have been devised to repair palate using one-stage or two-stage 
techniques (Haque and Alam, 2014b). One-stage technique involves approximating the soft 
and hard palate simultaneously in a single appointment. Whereas, in two-stage technique both 
are dealt with in separate appointments. Statistically, no significant difference of surgical 
outcome has been documented between one-stage and two-stage technique. Figure 2.8 shows 
major different techniques available for palatoplasty. 
24 
 
2.5.3.1 Von Langenbeck technique 
In 1861, Von Langenbeck (VL) introduced two-flap uranoplasty (palatoplasty), which is still 
practiced (Arosarena, 2007). Simplicity of design and the smaller dissection involved has led 
to its frequent use over the past century (Vig and Mercado, 2015). Main drawback of this 
procedure was the poor speech outcome, and minimal increase in length of soft palate (Dreyer 
and Trier, 1984). 
2.5.3.2 Veau-Wardill-Kilners’ pushback palatoplasty 
Recognizing the drawbacks of Von Langenbeck technique, efforts were made to design a 
technique which could address the issue of speech problems and short palatal length. To 
achieve sufficient palatal lengthening, one of the most commonly used technique was Veau-
Wardill-Kilners’ (VY) pushback palatoplasty (Kirschner and LaRossa, 2000). Because of the 
large scar area left intentionally for secondary healing there is increased risk of a palatal fistula 
formation which has led to its limited use (Krause et al., 1976). 
2.5.4 Alveolar process repair 
Primary and secondary alveolar bone grafting have been used to augment the defected area 
with a bone graft from various sources. Usually alveolar bone grafts are required to facilitate 
eruption process of permanent dentition, reduce nasal asymmetry, contouring arch and implant 
site preparation (Kajii et al., 2009; Dugas, 2010). The idea of primary alveolar bone grafts has 
been abandoned since the gold standard set by secondary alveolar bone replacement (Boyne 
and Sands, 1972; Meazzini et al., 2008).   
